Health Canada Grants Authorization for Leqembi® (lecanemab)
Go back to Health Canada Grants Authorization for Leqembi® (lecanemab)| BARNES GROUP, Inc. (NYSE: B) | Delayed: 36.68 -0.15 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.83 | 52 Week High | $44.27 | |||
| Open | $36.64 | 52 Week Low | $30.07 | |||
| Day High | $36.91 | P/E | 28.00 | |||
| Day Low | $36.25 | EPS | $1.31 | |||
| Volume | 4,640,216 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 24.34 -0.55 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.89 | 52 Week High | $8.73 | |||
| Open | $25.00 | 52 Week Low | $2.86 | |||
| Day High | $25.42 | P/E | N/A | |||
| Day Low | $22.72 | EPS | $-3.82 | |||
| Volume | 704,402 | |||||
